Personalized medicine with biologics for severe type 2 asthma: current status and future prospects

بواسطة Godar, Marie, Blanchetot, Christophe, de Haard, Hans, Lambrecht, Bart N., Brusselle, Guy
الحاوية / القاعدة MAbs (2017)

A bispecific antibody strategy to target multiple type 2 cytokines in asthma

بواسطة Godar, Marie, Deswarte, Kim, Vergote, Karl, Saunders, Michael, de Haard, Hans, Hammad, Hamida, Blanchetot, Christophe, Lambrecht, Bart N.
الحاوية / القاعدة J Allergy Clin Immunol (2018)

Dual anti-idiotypic purification of a novel, native-format biparatopic anti-MET antibody with improved in vitro and in vivo efficacy

بواسطة Godar, Marie, Morello, Virginia, Sadi, Ava, Hultberg, Anna, De Jonge, Natalie, Basilico, Cristina, Hanssens, Valérie, Saunders, Michael, Lambrecht, Bart N., El Khattabi, Mohamed, de Haard, Hans, Michieli, Paolo, Blanchetot, Christophe
الحاوية / القاعدة Sci Rep (2016)

Phase 2 study of efgartigimod, a novel FcRn antagonist, in adult patients with primary immune thrombocytopenia

بواسطة Newland, Adrian C., Sánchez‐González, Blanca, Rejtő, László, Egyed, Miklos, Romanyuk, Nataliya, Godar, Marie, Verschueren, Katrien, Gandini, Domenica, Ulrichts, Peter, Beauchamp, Jon, Dreier, Torsten, Ward, E. Sally, Michel, Marc, Liebman, Howard A., de Haard, Hans, Leupin, Nicolas, Kuter, David J.
الحاوية / القاعدة Am J Hematol (2019)